China’s MOH Further Standardizes Centralized Drug Purchase Online
This article was originally published in PharmAsia News
China's Ministry of Health and five other state agencies recently signed an opinion draft on further standardizing centralized drug purchases in heath care institutions. According to the document, online centralized drug purchase implementation will be led by the government, with each province (including autonomous regions and municipalities) as a purchasing unit. To reduce drug distribution costs, pharmaceutical manufacturers will now be the direct bidders instead of drug wholesalers. Industry analysts believe that the policy will facilitate the establishment of a new drug purchase and sales system: first, market focus of drug manufacturing will be heightened; the drug distribution structure will change, as will sales patterns of prescription drugs. However, analysts think these will have little impact on the current drug agent model. (Click here for more - Chinese Language)
You may also be interested in...
The FAST 01 feasibility trial is evaluating a modification to Varian’s ProBeam particle accelerator that enables ultra-high dose radiation to treat cancer.
AstraZeneca's research head admits that half dose approach was a lucky mistake - but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.
HBW Insight speaks to new Global Self-Care Federation chair and Bayer CH chief Heiko Schipper about the role that self-care can play in alleviating pressure on national health care systems, the importance of self-care's scientific credentials and of maintaining supply chain continuity during the coronavirus pandemic.